New clinical trial now open

A new clinical trial has opened recently at several hospitals and has recruited four patients so far. The NEMO study investigates the activity of the drug Nintedabib in a double-blind, randomized phase II study.

Patients can be considered after completing four to six cycles of first line platinum-based chemotherapy for plueral mesothelioma and after confirmation of absence of progressive disease.

Recruiting sites are at:

Weston Park Hospital, Sheffield
Royal Marsden Hospital, Chelsea, London
Royal Marsden Hospital, Sutton, Surrey
South Tyneside District Hospital
UHSM Wythenshawe Hospital
and Royal Marsden Hospital, Kingston Hospital.

These centres are in set-up and will open in due course:

St James’ University Hospital, Leeds
Mount Vernon Hospital, Hertfordshire
Maidstone Hospital
Musgrove Park Hospital, Taunton

More details can be found at

Introducing the new Health Companion portal

Working in collaboration with DaSH-Global, a pharmaceutical manufacturing company, we have developed a new digital patient portal known as the ‘Health Companion’. The new system will allow patients to submit data regarding their quality of life and experiences in the...

Join our Asbestos Commercial Club

If you are a business involved in the management of asbestos or the diseases it causes, why not join our Asbestos Commercial Club (MUKACC) to support the vital work that we do? Joining MUKACC can be a great morale booster for your staff, encouraging them to get...

CEO Liz Darlison to speak at the European Asbestos Conference

Mesothelioma UK’s CEO, Liz Darlison, has been confirmed as a speaker at the European Asbestos Forum Conference (EAF). The event will take place from 10-11 November in Amsterdam, in the Netherlands, where she will deliver a talk entitled, Establishing a National...

Mesothelioma National Statistics

The Health and Safety Executive has been publishing statistics on annual mesothelioma deaths in Great Britain on a consistent basis for 50 years. Detailed statistical tables and commentary are available as part of HSE’s National Statistics web pages here. The data...